Acceleron Pharma reported $-70450000 in Pre-Tax Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acceleron Pharma XLRN:US $ -70.45M 6.94M
Akebia Therapeutics AKBA:US $ -59.54M 23.49M
Alexion Pharmaceuticals ALXN:US $ 940.1M 164.6M
Arena Pharmaceuticals ARNA:US $ -126.31M 19.78M
Bluebird Bio BLUE:US $ -216.93M 14.49M
Clovis Oncology CLVS:US $ -67.4M 0.95M
Dicerna Pharmaceuticals DRNA:US $ -16.26M 24.01M
Eli Lilly And LLY:US $ 1470.5M 518.1M
Exelixis EXEL:US $ 53.26M 71.63M
Johnson & Johnson JNJ:US $ 8058M 282M
Karyopharm Therapeutics KPTI:US $ -51706000 1.74M
Mirati Therapeutics MRTX:US $ -76.76M 89.68M
Neurocrine Biosciences NBIX:US $ 30.5M 27M
Novartis NOVN:VX SF 4544M 120M
Ptc Therapeutics PTCT:US $ -133.66M 15.78M
Puma Biotechnology PBYI:US $ -20.14M 15.04M
Regeneron Pharmaceuticals REGN:US $ 1822.2M 2076.1M
Rigel Pharmaceuticals RIGL:US $ -21.09M 6.3M
Sangamo Biosciences SGMO:US $ -47.6M 0.45M
Tg Therapeutics TGTX:US $ -85.64M 7.14M
Ultragenyx Pharmaceutical RARE:US $ -72.82M 49.15M
United Therapeutics UTHR:US $ 204.4M 12.1M